AI Briefing#biotechnology
The latest AI and developer news about #biotechnology, with the original source and a short summary.
The latest AI and developer news about #biotechnology, with the original source and a short summary.
Collaborations with partners like Generate Biomedicines and Divergence Labs yielded specific results, including a 70% shorter CAR T-cell design and 35,000 antibody designs generated in one month.
Claude has demonstrated the ability to dramatically increase research speed in protein design and analytical chemistry.
OpenAI has released case studies of Genebench-Pro, a benchmark that evaluates the ability to analyze biological data.
Immunologist Derya Unutmaz used GPT-5 Pro to solve the mystery of an experiment from 3 years ago related to T cell differentiation.
An AI-designed 'super-antigen' vaccine has entered the world's first human clinical trial to counter mutating viruses.
A new DNA synthesis technology called 'Sidewinder' has been developed that quickly and accurately implements genetic sequences designed by generative AI.
Biohub has unveiled an AI-powered world model for predicting protein structures and designing new proteins.
An immunology professor predicted that AI-driven acceleration of scientific discovery could make it possible to cure all diseases within 10 years.
OpenAI has launched GPT-Rosalind, a specialized model that accelerates life sciences research and drug design.
OpenAI partnered with Ginkgo Bioworks to build a GPT-5-based autonomous lab that cut cell-free protein synthesis costs by 40%.
OpenAI and Retro Biosciences increased stem cell reprogramming efficiency by 50x using GPT-4b micro, a model specialized for protein engineering.
Biotech company Genmab has rolled out ChatGPT Enterprise company-wide to transform its research and business processes.